Targeted surgical parathyroidectomy in end-stage renal disease patients and long-term metabolic control: A single-center experience in the current era-Reference-Cited by-同舟云学术

Targeted surgical parathyroidectomy in end-stage renal disease patients and long-term metabolic control: A single-center experience in the current era

Published:2018-02-15 Issue:3 Volume:22 Page:394-404
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Fülöp Tibor¹^ORCID,Koch Christian A.²³⁴,Farah Musa Abdeen R.¹,Clark Christopher M.⁵,Gharaibeh Kamel A.¹,Lengvársky Zsolt⁶,Hamrahian Mehrdad⁷,Pitman Karen T.⁸,Dixit Mehul P.⁹

Affiliation:

1. Division of Nephrology; Diabetes and Metabolism, Department of Medicine, University of Mississippi Medical Center; Jackson Mississippi USA

2. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine; University of Mississippi Medical Center; Jackson Mississippi USA

3. G.V. (Sonny) Montgomery VA Medical Center; Jackson Mississippi USA

4. Cancer Institute, University of Mississippi Medical Center; Jackson Mississippi USA

5. Department of Otolaryngology - Head and Neck Surgery; University of Texas Southwestern; Dallas Texas USA

6. Department of Mathematics; Louisiana State University Shreveport; Shreveport Louisiana USA

7. Thomas Jefferson University; Philadelphia Pennsylvania USA

8. Johns Hopkins Department of Otolaryngology; Milton J. Dance Jr. Head and Neck Center; Baltimore Maryland USA

9. Division of Pediatric Nephrology, Department of Pediatrics; University of Mississippi Medical Center; Jackson Mississippi USA

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hdi.12639/fullpdf

Reference58 articles.

1. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS);Tentori;Am J Kidney Dis.,2008

2. Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients;Streja;Bone.,2014

3. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD);Group KDIGOC-MW;Kidney Int Suppl.,2009

4. Effects of treatment of renal osteodystrophy on bone histology;Malluche;Clin J Am Soc Nephrol.,2008

5. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy;Teng;N Engl J Med.,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of chronic kidney disease: The current novel and forgotten therapies;Journal of Clinical & Translational Endocrinology;2024-06

2. Forestalling Hungry Bone Syndrome after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism;Diagnostics;2023-06-02

3. Construction and validation of a predictive model for hypocalcemia after parathyroidectomy in patients with secondary hyperparathyroidism;Frontiers in Endocrinology;2022-11-30

4. Bone Mineral Disease After Kidney Transplantation;Calcified Tissue International;2021-03-25

5. Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism;Renal Failure;2020-01-01